A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity

Similar Items

• Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
  od: Price, David, i dr.
  Izdano: (2013)
• A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
  od: Hellings, Peter, i dr.
  Izdano: (2013)
• A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
  od: Price, David, i dr.
  Izdano: (2013)
• A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
  od: Bachert, Claus, i dr.
  Izdano: (2013)
• A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
  od: Hellings, Peter, i dr.
  Izdano: (2015)